KOZARICH JOHN W sold 1.1% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $88.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 1/6/2026ACC: 0002001011-26-000004
-467.00
Net shares
Net seller
$88.5K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
467.00 disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−21.00
Price / share
$186.59
Trade value
$3.92K
% of position
0.0%
1/2/2026
44.12K→44.10K
Common Stock
Direct
Shares
−91.00
Price / share
$187.95
Trade value
$17.10K
% of position
0.2%
1/2/2026
44.10K→44.01K
Common Stock
Direct
Shares
−102.00
Price / share
$188.96
Trade value
$19.27K
% of position
0.2%
1/2/2026
44.01K→43.91K
Common Stock
Direct
Shares
−207.00
Price / share
$190.27
Trade value
$39.39K
% of position
0.5%
1/2/2026
43.91K→43.70K
Common Stock
Direct
Shares
−46.00
Price / share
$192.40
Trade value
$8.85K
% of position
0.1%
1/2/2026
43.70K→43.65K
Total
Net shares
−467.00
Net value
-$88.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | S · Sale | −21.00 | $186.59 | $3.92K | 0.0% | 44.12K | 44.10K |
| Common Stock Direct | 1/2/2026 | S · Sale | −91.00 | $187.95 | $17.10K | 0.2% | 44.10K | 44.01K |
| Common Stock Direct | 1/2/2026 | S · Sale | −102.00 | $188.96 | $19.27K | 0.2% | 44.01K | 43.91K |
| Common Stock Direct | 1/2/2026 | S · Sale | −207.00 | $190.27 | $39.39K | 0.5% | 43.91K | 43.70K |
| Common Stock Direct | 1/2/2026 | S · Sale | −46.00 | $192.40 | $8.85K | 0.1% | 43.70K | 43.65K |
| Total | −467.00 | -$88.53K | ||||||
Derivative Transactions0
No derivative transactions reported